Drug Detail

Information about Imatinib + Fampridine

Generic Name
Imatinib + Fampridine
IND
Brand Name (US)
Manufacturer
Drug Type
Delivery
Oral
Approval Status
Indications
Overall Strategy
Synthetic lethality
Strategy
Inhibit cell proliferation and migration/invasion, as well as induce apoptosis
Drug Category
KIT + VGKC inhibitor


Links


Trials of this drug

  

Neoadjuvant Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor
   

Trial results


Search for this drug/combination in:

ClinicalTrials.gov

ASCO

Pubmed